Loading clinical trials...
Loading clinical trials...
A Phase 1, Randomized, Double Blind, Placebo-Controlled, Single Dose Escalation Study In Japanese Healthy Subjects, And Open Label, Single Dose Study In Western Healthy Subjects To Investigate The Safety, Tolerability, And Pharmacokinetics of PF-04991532.
Conditions
Interventions
PF-04991532
Placebo
+1 more
Locations
1
United States
Pfizer Investigational Site
New Haven, Connecticut, United States
Start Date
June 1, 2011
Primary Completion Date
September 1, 2011
Completion Date
September 1, 2011
Last Updated
September 22, 2011
NCT07051005
NCT00001987
NCT07480161
NCT04786262
NCT06748963
NCT06887049
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions